10-10/11 :: October/November 2010

nanotimes EU-Projects

Sabio. This completed project focused on ultrahigh sensitivity slot-waveguide biosensor on a highly in- tegrated chip for simultaneous diagnosis of multiple diseases.

http://ist-sabio.org http://www.siliconphotonics.eu/ Low Cost Inks for Printed Electronics

The Clip project aiming at developing low cost inks for printed electronics applications was launched. The EUR2.7 million large project will enable small and medium sized EU based businesses to address the growing potential of printed electronics. Clip is financed under the EU‘s 7th Framework programme for Research and Technological Development (FP7), Research for SME Associations programme.

Over the last 20 years the sophistication of printing systems and technology has grown to a point where the next step towards realising printed electronics will be in reach for a range of applications and com- panies, including SMEs. However, to do this, there is a need for a low cost conductive ink, which can act as the platform for developing more complicated and valuable technologies. This will accelerate the time to market for new electronic enabled products by utilising printing technologies that already exist within the EU. http://www.clip-fp7.eu/press

65

Mapping the Success of Nanobiotechnology

The crucial task of the EU-funded project Euron- anobio was to set out a research path to steer the European nanobiotech industry to success over the shortest time in the most efficient way. The main aim was to define the capacity of nanobiotechnology in Europe and then chart the appropriate roadmap for its implementation.

First, project members analysed the present systems and networks in research, education and training. Once this was in place, all stakeholders were invited to give their opinion as to how to extend this com- plex infrastructure. Key players come from govern- ments, research, industry, and, all-importantly for any biotech initiative, advisors on ethics.

Euronanobio proposed no less than 15 recommen- dations for a distributed biotech European network. These involved four dimensions – research, educa- tion, technology transfer and ethical legal and so- cial aspects (ELSA). High level dissemination of the findings through the internet and conferences will help to maintain the rapid yet stable evolution of nanobiotechnology.

Contact: Patrick Boisseau, COMMISSARIAT ENERGIE ATOMIQUE CEA, LETI, Project manager, 17, avenue des martyrs, 38054 Grenoble, France, Phone: +33-4- 38783854 http://www.euronanobio.eu